[1] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会, 《中国循环杂志》编辑委员会. 急性心肌梗死诊断和治疗指南 [J]. 中华心血管病杂志 2001. [2] 杨跃进. 经皮冠状动脉介入治疗中无再流的诊断、治疗和预防 [J]. 中华心血管病杂志 2004.doi:10.3760/j:issn:0253-3758.2004.07.035 [3] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员. 经皮冠状动脉介入治疗指南 [J]. 中国循环杂志 2003. [4] RESNIC F S, WAINSTEIN M, LEE M K. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention [J]. American Heart Journal 2003, 145(01). [5] 马长生. 冠心病介入治疗-技术与策略 [M]. 北京:人民卫生出版社 2004. [6] TIMI Study Croup. The thrombolysis in myocardial infarction(TIMI) trial [J]. the New England Journal of Medicine 1985, 312(04). [7] Sakuma T, Leong Poi H, Fisher NG, Goodman NC, Kaul S. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli. [J]. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography 2003, 1(1). [8] MIZOTE I, UEDA Y, OHTANI T. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardialinfarction who had angioscopically defined ruptured plaque [J]. Circulation 2005, 112(07). |